New cholesterol drugs good for patients, may drive up costs

Stephen Feller
SAN FRANCISCO, Aug. 17 (UPI) — Researchers say cholesterol-lowering PCSK9 inhibitors could reduce heart attacks, strokes and death but may be “cost-prohibitive” for widespread U.S. use. …read more

Source:: National and World Stories

      

You must be logged in to post a comment Login